NAUT
Nautilus Biotechnology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.97
−0.59%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 82.78x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.94x
- Price / sales
- 646.99x
- Price / cash flow
- -2.45x
Enterprise value
- Enterprise value
- $66.7M
- EV / sales
- 351.12x
- EV / EBITDA
- -1.21x
- EV / EBIT
- -1.06x
- Market cap
- $122.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026